| Net Cash Provided by (Used in) Operating Activities |
$28,590 |
USD |
|
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$21,494 |
USD |
7.1% |
Q3 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
14,027,834 |
shares |
0% |
Q3 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$29,414 |
USD |
3765% |
Q3 2025 |
Q1 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
-100% |
Q3 2025 |
Q1 2026 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q3 2024 |
Q1 2025 |
| Deferred Tax Assets, Gross |
$194,300 |
USD |
5.9% |
Q2 2025 |
FY 2025 |
| Property, Plant and Equipment, Gross |
$700 |
USD |
0% |
Q3 2025 |
Q1 2026 |
| Deferred Income Tax Expense (Benefit) |
$0 |
USD |
|
Q3 2024 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$182,500 |
USD |
5.2% |
Q2 2025 |
FY 2025 |
| Current Income Tax Expense (Benefit) |
$0 |
USD |
|
Q3 2024 |
Q1 2025 |
| Additional Paid in Capital |
$433,209 |
USD |
0% |
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q2 2025 |
FY 2025 |
| Interest Expense |
$10,277 |
USD |
-1.4% |
Q2 2025 |
FY 2025 |